These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5935107)

  • 21. [THE DEVELOPMENT OF THROMBOCYTE COUNT FOLLOWING EXCHANGE TRANSFUSION IN INFANCY].
    DUX E; KOVACS Z; PATAKI L
    Orv Hetil; 1963 Sep; 104():1641-5. PubMed ID: 14054562
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the antigenicity of factors A and B in the newborn].
    Ducos J; Ohayon E; Marty Y
    Rev Fr Transfus; 1969; 12(1):Suppl:37-43. PubMed ID: 5393863
    [No Abstract]   [Full Text] [Related]  

  • 23. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood group sensitization in the newborn. The indications for exchange transfusion and its hazards.
    Heese HD
    S Afr Med J; 1966 Feb; 40(7):136-40. PubMed ID: 5948691
    [No Abstract]   [Full Text] [Related]  

  • 26. [A case of hemolytic disease of the newborn caused by materno-fetal isoimmunization against factor c(hr') (preliminary note)].
    De Luca P
    Arch Ostet Ginecol; 1980; 85(3):175-7. PubMed ID: 6802114
    [No Abstract]   [Full Text] [Related]  

  • 27. [Isoimmunization in the ABO system caused by obstetrician or pregnancy complications (control groups)].
    Sauer J; Kulich V
    Zentralbl Gynakol; 1965 Dec; 87(52):1780-8. PubMed ID: 5885709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biochemical and hematometric effects of exchange transfusion in isoimmunized neonates].
    Jurfest-Ceccon ME; de Albuquerque Diniz EM; de Araujo-Ramos JL; Costa-Vaz FA
    Bol Med Hosp Infant Mex; 1993 Mar; 50(3):167-76. PubMed ID: 8442881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of neonatal ABO immunization which was difficult to diagnose. The mother with blood group A2 and the infant with negative direct antiglobulin test].
    Kumlien G; Sarman I; Shanwell A
    Lakartidningen; 2000 Sep; 97(38):4138-40. PubMed ID: 11068380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cause of death in erythroblastosis fetalis.
    Emanuel B; Sanson J
    GP; 1966 Apr; 33(4):110-3. PubMed ID: 5905806
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 32. [Some cases of ABO incompatibility].
    Sudan JP; Brochery PC; Erny R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(1):63-5. PubMed ID: 5685127
    [No Abstract]   [Full Text] [Related]  

  • 33. [HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY ISOIMMUNIZATION WITH ANTI-'C(HR')].
    CALKOVSKA SIGIDOVA Z; MARTINKOVIC A
    Cesk Pediatr; 1963 Jul; 18():599-604. PubMed ID: 14056307
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 36. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with immunodepressant drugs in neonatal hemolytic disease caused by Rh isoimmunization (preliminary note)].
    De Luca P; Merlino G
    Arch Ostet Ginecol; 1980; 85(3):169-73. PubMed ID: 6802113
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case of maternal-fetal anti-E isoimmunization].
    Fanciulli G; Sechi T
    Minerva Ginecol; 1970 Apr; 22(8):430-1. PubMed ID: 5530542
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemolytic disease of the newborn as a result of ABO incompatibility and unusual fetogenic sensitizations].
    DAMEROW R
    Ergeb Inn Med Kinderheilkd; 1963; 19():132-205. PubMed ID: 14024821
    [No Abstract]   [Full Text] [Related]  

  • 40. Estimation of the number of females at risk of isoimmunization to the Rho (D) antigen in a sample of the population attended at the Instituto Mexicano del Seguro Social.
    Zavala C; Velázquez-Ferrari MA; Navarrete C; Rosales-Corona J; Lisker R
    Arch Invest Med (Mex); 1983; 14(2):199-206. PubMed ID: 6416200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.